Esophageal cancer on the rise among young Americans
By (0)
Esophageal cancer accounts for about 1% of U.S. cancer diagnoses, and just over 18,000 cases are expected to be diagnosed nationwide this year. Photo by Anastasia Gepp/Pixabay
Esophageal cancer is increasing among young Americans, and they re more likely to be diagnosed with advanced disease, according to a new study.
Esophageal cancer accounts for about 1% of U.S. cancer diagnoses, and just over 18,000 cases are expected to be diagnosed nationwide this year. Only one in five patients is alive five years after diagnosis.
Advertisement
In the new study, researchers analyzed data on esophageal adenocarcinoma (EAC) - one of the most common types of esophageal cancer in the United States between 1975 and 2015.
Article content
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Oxygen level while walking identifies at-risk patients
We apologize, but this video has failed to load.
Try refreshing your browser, or Oxygen level while walking identifies at-risk patients; cancer patients should get vaccine priority Back to video
It can be helpful to assess blood oxygen levels in patients when they are walking if that level is normal when they are sitting, a new study suggests. A low level of oxygen in the blood, or hypoxia, contributes to shortness of breath and worsening illness in patients with COVID-19. At 10 Chicago-area hospitals, doctors studied 531 COVID-19 patients whose blood oxygen levels were normal at rest. Roughly one in four developed hypoxia when they got up and walked. These individuals were nearly five times more likely to eventually need bas
Use of oral contraceptive pills linked to reduction in endometrial and ovarian cancer risks, study finds Despite its widespread use and benefits, oral contraceptive pills are often associated with a number of myths and risk factors for other diseases, especially cancers Representational image. Pixabay
Ever since the 1960s, the oral contraceptive pill has been adopted by women across the world as a method of not just family planning but also of treating or managing reproductive health disorders like polycystic ovary syndrome (PCOS), uterine fibroids and endometriosis.
Over the years, contraceptive pills have evolved to be inclusive of most women and give them the maximum amount of control over their reproductive health. Despite its widespread use and benefits, the pill (as oral contraceptive pills are often referred to) is often associated with a number of myths and risk factors for other diseases, especially cancers.
A single dose of the bivalent human papillomavirus (HPV) vaccine (Cervarix) offers a similar level of protection against the HPV-16/18 infections - which cause about 70% of cervical cancers - as current two- and three-dose schedules, according to data from two large phase 3 trials.
Worldwide, cervical cancer is the fourth most common cancer in women. The bivalent vaccine targets HPV types 16 and 18 that are responsible for about 70% of cervical cancers. The HPV-16/18 vaccine was initially approved to be given in three doses over 6 months, but many countries are moving to a two-dose schedule in adolescents.
This new combined analysis of two independent trials strengthens previous findings from the NCI Costa Rica HPV Vaccine Trial (CVT) which reported that young women who received three, two, or one dose of the bivalent vaccine were equally protected against infection with HPV-16/18 for at least 4 years after vaccination.
Bilim insanları asbest temasıyla ortaya çıkan akciğer zarı kanserine neden olan geni buldu haberturk.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from haberturk.com Daily Mail and Mail on Sunday newspapers.